2014
DOI: 10.1016/j.ejvs.2014.03.009
|View full text |Cite
|
Sign up to set email alerts
|

Ocular Defects as Surrogate End-Points in Trials Comparing Carotid Endarterectomy and Stenting

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 16 publications
0
1
0
Order By: Relevance
“…12 However, emboli generated during surgical treatment of ICA stenosis may also induce ischemic lesions of the ophthalmic artery, impacting on eye circulation and potentially leading to postoperative ocular defects. 13,14 So far, the effect of ICA stenosis and its surgical treatment on the choroidal structure has been poorly evaluated.…”
Section: Introductionmentioning
confidence: 99%
“…12 However, emboli generated during surgical treatment of ICA stenosis may also induce ischemic lesions of the ophthalmic artery, impacting on eye circulation and potentially leading to postoperative ocular defects. 13,14 So far, the effect of ICA stenosis and its surgical treatment on the choroidal structure has been poorly evaluated.…”
Section: Introductionmentioning
confidence: 99%
“…[14] With the rapid development of proximal and distal embolus protection devices and advances in techniques, CAS has gained reliability in terms of complications and now has comparable results to conventional CEA. [15] There are studies indicating that CAS therapy or CEA increases cerebral and retinal blood flow, [16][17][18] as well as studies suggesting that the CAS method is effective in the treatment of ocular ischemic syndrome. [2,19,20] Despite improvements in techniques, intravascular procedures are a well-known accelerating factor for thromboembolic events.…”
Section: Discussionmentioning
confidence: 99%